Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma
Keren Isaev(Ontario Institute for Cancer Research), Robert Kridel(University of Toronto), Laura K. Hilton(BC Cancer Agency), Kerry J. Savage(Spinal Cord Injury BC), Rosemarie Tremblay‐LeMay(University Health Network), Anjali Silva(University Health Network), Susana Ben‐Neriah(Apple (Israel)), Randy D. Gascoyne(BC Cancer Agency), Diego Villa(BC Cancer Agency), Christian Steidl(University of British Columbia), Andrew J. Mungall(Spinal Cord Injury BC), David W. Scott(Spinal Cord Injury BC), Brian Skinnider(Spinal Cord Injury BC), Daisuke Ennishi(BC Cancer Agency), Marco A. Marra(University of British Columbia), Ryan D. Morin(Simon Fraser University), Merrill Boyle, Karen Mungall(Brown University), Mehran Bakhtiari(University Health Network)
Cited by 15
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k